Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Main Capital and Optimizers group in connection with the acquisition of Vendre
Mandate

Vinge advises Main Capital and Optimizers group in connection with the acquisition of Vendre

January 30, 2023 Employment and Benefits Commercial Agreements Intellectual Property M&A IT, Telecommunications and Outsourcing Data protection and processing of personal data

Vendre is a provider of an innovative module-based eCommerce platform for customers in both B2B and B2C markets

Vendre AB was founded in 2007 and provides an innovative eCommerce platform with several different and unique functionalities to its over one hundred customers. Through the acquisition, Main Capital’s portfolio company Optimizers strengthens its product offering and position in the Nordic market, growing towards EUR 25 million in revenues and 170 employees.

Vinge’s team mainly consisted of Filip Öhrner, Olivia Belding, Nando Basic (M&A), Ebba Svenburg (Employment), Martin Boström (Commercial Agreements) Lisa Hörnqvist (IT and GDPR), Rebecka Målquist, Johan Gavelin (IP) and Ellinore Boström Andersson (project assistant).

Related

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of their production facility in Uppsala to Ofichem. The Uppsala site specializes in small-scale, early-phase development work.
August 13, 2025

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

 Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025